The findings highlight the pathophysiological roles of microglial EVs in POCD and suggest a new therapeutic approach potentially applicable to other neuroinflammatory or neurodegenerative diseases via the CCR5‐GPCRs‐Ras‐MAPK signaling pathway. Here, CCR5 is linked to neurodegenerative disease.